Lung

, Volume 190, Issue 1, pp 41–44

Therapeutic Options for Acute Cough Due to Upper Respiratory Infections in Children

Article

Abstract

Cough due to upper respiratory tract infections (URIs) is one of the most frequent complaints encountered by pediatric health-care providers, and one of the most disruptive symptoms for children and families. Despite the frequency of URIs, there is limited evidence to support the few therapeutic agents currently available in the United States (US) to treat acute cough due to URI. Published, well-designed, contemporary research supporting the efficacy of narcotics (codeine, hydrocodone) and US Food and Drug Administration (FDA)-approved over-the-counter (OTC) oral antitussives and expectorants (dextromethorphan, diphenhydramine, chlophedianol, and guaifenesin) is absent for URI-associated pediatric cough. Alternatively, honey and topically applied vapor rubs may be effective antitussives.

Keywords

Cough Upper respiratory tract infections Child Dextromethorphan Guaifenesin 

References

  1. 1.
    Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA (2008) Cough and cold medication use by US children, 1999–2006: results from the slone survey. Pediatrics 122:e323–e329PubMedCrossRefGoogle Scholar
  2. 2.
    American Academy of Pediatrics Committee on Drugs (1997) Use of codeine- and dextromethorphan-containing cough remedies in children. Pediatrics 99:918–920CrossRefGoogle Scholar
  3. 3.
    Department of Child, Adolescent Health (2001) Cough and cold remedies for the treatment of acute respiratory infections in young children. World Health Organization, GenevaGoogle Scholar
  4. 4.
    Schroeder K, Fahey T (2002) Should we advise parents to administer over the counter cough medicines for acute cough? Systematic review of randomised controlled trials. Arch Dis Child 86:170–175PubMedCrossRefGoogle Scholar
  5. 5.
    Smith SM, Schroeder K, Fahey T (2008) Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (1):CD001831. doi:10.1002/14651858.CD001831.pub3
  6. 6.
    Chang AB, Glomb WB (2006) Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest 129:260S–283SPubMedCrossRefGoogle Scholar
  7. 7.
    Shields MD, Bush A, Everard ML, McKenzie S, Primhak R (2008) BTS guidelines: recommendations for the assessment and management of cough in children. Thorax 63(Suppl 3):iii1–iii15PubMedGoogle Scholar
  8. 8.
    Cass LJ, Frederik WS (1953) Evaluation of a new antitussive agent. N Engl J Med 249:132–136PubMedCrossRefGoogle Scholar
  9. 9.
    Rodriguez W, Selen A, Avant D et al (2008) Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics 121:530–539PubMedCrossRefGoogle Scholar
  10. 10.
    Reece CA, Cherry AC Jr, Reece AT, Hatcher TB, Diehl AM (1966) Tape recorder for evaluation of coughs in children. Am J Dis Child 112:124–128PubMedGoogle Scholar
  11. 11.
    U.S. Food and Drug Administration (2011) Over-the-counter (OTC) monograph process. http://fdadrugcompliance.com/resources/otc/. Accessed 28 June 2011
  12. 12.
    Department of Health, Education, Welfare, Food, Drug Administration (1976) Over-the-counter drugs: establishment of a monograph for OTC cold, cough, allergy, bronchodilator, and antiasthmatic products. Federal Regist 41:38212–38424Google Scholar
  13. 13.
    Department of Health, Education, Welfare, Food, Drug Administration (1987) Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final monograph for OTC antitussive drug products. Fed Regist 52:30042–30057Google Scholar
  14. 14.
    Department of Health, Education, Welfare, Food, Drug Administration (1989) Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; expectorant drug products for over-the-counter human use; final monograph. Fed Regist 54:8494–8509Google Scholar
  15. 15.
    Korppi M, Laurikainen K, Pietikainen M, Silvasti M (1991) Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 80:969–971PubMedCrossRefGoogle Scholar
  16. 16.
    Taylor JA, Novack AH, Almquist JR, Rogers JE (1993) Efficacy of cough suppressants in children. J Pediatr 122:799–802PubMedCrossRefGoogle Scholar
  17. 17.
    Paul IM, Yoder KE, Crowell KR et al (2004) Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 114:e85–e90PubMedCrossRefGoogle Scholar
  18. 18.
    Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, Berlin CM Jr (2007) Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 161:1140–1146PubMedCrossRefGoogle Scholar
  19. 19.
    Shadkam MN, Mozaffari-Khosravi H, Mozayan MR (2010) A comparison of the effect of honey, dextromethorphan, and diphenhydramine on nightly cough and sleep quality in children and their parents. J Altern Complement Med 16:787–793PubMedCrossRefGoogle Scholar
  20. 20.
    Unuvar E, Yildiz I, Kilic A et al (2007) Is acetaminophen as effective as an antihistamine-decongestant-acetaminophen combination in relieving symptoms of acute nasopharyngitis in children? A randomised, controlled trial. Int J Pediatr Otorhinolaryngol 71:1277–1285PubMedCrossRefGoogle Scholar
  21. 21.
    Paul IM, Beiler JS, King TS, Clapp ER, Vallati J, Berlin CM Jr (2010) Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics 126:1092–1099PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Departments of Pediatrics and Public Health Sciences, HS83Penn State College of MedicineHersheyUSA

Personalised recommendations